Résumé
L’incidence du cancer de l’endomètre a atteint 6 800 cas en 2011 en France pour une mortalité de 2 080 cas, alors que le taux d’incidence standardisé à la population européenne était de 13,6 pour 100 000 femmes en 2005 [1]. Sur le plan épidémiologique, on considère qu’il existe deux types de cancers de l’endomètre: un type œstrogéno-dépendant peu agressif et bien différencié (carcinome endométrioïde de grade 1, 2) et un type œstrogéno-indépendant, plus agressif (carcinome endométrioïde de grade 3, carcinome séreux ou à cellules claires) [6]. Par ailleurs, le tamoxifène, largement utilisé pour son effet protecteur vis-à-vis du cancer du sein, a un effet œstrogène-like sur l’endomètre. Son utilisation augmente le risque de développer un cancer de l’endomètre [7, 8].
Preview
Unable to display preview. Download preview PDF.
Références
Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105: 103–4
Haie-Meder C, Fervers B, Chauvergne J, et al. (2000) Radiochimiothérapie concomitante dans les cancers du col de l’utérus: analyse critique des données et mise à jour des Standards, Options et Recommandations. Cancer Radiother 4: 60–75
Kodaira T, Fuwa N, Toita T, et al. (2003) Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 56: 769–77
Messiou C, Morgan VA, De Silva SS, et al. (2009) Diffusion weighted imaging of the uterus: regional ADC variation with oral contraceptive usage and comparison with cervical cancer. Acta Radiol 50: 696–701
Whittaker CS, Coady A, Culver L, et al. (2009) Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review. Radiographics 29: 759–774; discussion 774–58
Narducci F, Lambaudie E, Sonoda Y, et al. (2003) Endometrial cancer: what’s new? Gynecol Obstet Fertil 31: 581–96
Fisher B, Costantino JP, Redmond CK, et al. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86: 527–37
Mourits MJ, De Vries EG, Willemse PH, et al. (2001) Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 97: 855–66
Kodama S, Kase H, Tanaka K, Matsui K(1996) Multivariate analysis of prognostic factors in patients with endometrial cancer. Int J Gynaecol Obstet 53: 23–30
Larson DM, Connor GP, Broste SK, et al. (1996) Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 88: 394–8
Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105: 109
Kitchener H, Swart AM, Qian Q, et al. (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373: 125–36
Leblanc E, Querleu D, Castelain B, et al. (2000) Laparoscopic surgery in gynecologic oncology in 2000. Bull Cancer 87: 76–85
Blake P, Swart AM, Orton J, et al. (2009) Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 373: 137–46
Gull B, Karlsson B, Milsom I, Granberg S (2003) Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol 188: 401–8
Kinkel K, Forstner R, Danza FM, et al. (2009) Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol 19: 1565–74
Kinkel K, Kaji Y, Yu KK, et al. (1999) Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212: 711–8
Manfredi R, Mirk P, Maresca G, et al. (2004) Local-regional stzaging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231: 372–8
Rieck GC, Bulman J, Whitaker R, Leeson SC (2005) A retrospective review of magnetic resonance imaging in assessing the extent of myometrial infiltration for patients with endometrial carcinoma. J Obstet Gynaecol 25: 765–8
Taieb S, Ceugnart L, Leblanc E, et al. (2002) [MR imaging of endometrial carcinoma: role and limits]. Bull Cancer 89: 963–8
Rechichi G, Galimberti S, Signorelli M, et al. (2010) Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T. Eur Radiol 20: 754–62
Murphy GP LW, Lenhard RE (1995) Gynecologic sarcomas. In: Society AC (ed) American Cancer Society, Textbook of Clinical Oncology. 2nd ed., Atlanta GA, p. 573
Leibsohn S, d’Ablaing G, Mishell DR, Jr, Schlaerth JB (1990) Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 162:968–974; discussion 974–66
Zaloudek C NH (1989) Mesenchymal tumors. In: RJ K (ed) Blaustein’s pathology of the female genital tract. 3rd ed., New York, Springer-Verlag, p. 373
Takamizawa S, Minakami H, Usui R, et al. (1999) Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas. Gynecol Obstet Invest 48: 193–6
Tanaka YO, Nishida M, Tsunoda H, et al. (2004) Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging 20: 998–1007
Tanaka YO, Tsunoda H, Minami R, et al. (2008) Carcinosarcoma of the uterus: MR findings. J Magn Reson Imaging 28: 434–9
Gandolfo N, Gandolfo NG, Serafini G, Martinoli C (2000) Endometrial stromal sarcoma of the uterus: MR and US findings. Eur Radiol 10: 776–9
Goto A, Takeuchi S, Sugimura K, Maruo T (2002) Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 12: 354–61
Ueda M, Otsuka M, Hatakenaka M, et al. (2001) MR imaging findings of uterine endometrial stromal sarcoma: differentiation from endometrial carcinoma. Eur Radiol 11:28–33
Ueda M, Otsuka M, Hatakenaka M, Torii Y (2000) Uterine endometrial stromal sarcoma located in uterine myometrium: MRI appearance. Eur Radiol 10: 780–2
Parker WH, Fu YS, Berek JS (1994) Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83: 414–8
Common AA, Mocarski EJ, Kolin A, et al. (2001) Therapeutic failure of uterine fibroid embolization caused by underlying leiomyosarcoma. J Vase Interv Radiol 12: 1449–52
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2014 Springer-Verlag Paris
About this chapter
Cite this chapter
Balleyguier, C. et al. (2014). Cancers du corps utérin. In: IRM du pelvis de l’homme et de la femme. Springer, Paris. https://doi.org/10.1007/978-2-8178-0428-6_13
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0428-6_13
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0427-9
Online ISBN: 978-2-8178-0428-6
eBook Packages: MedicineMedicine (R0)